The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis

Monica Cardone, Ayten Kandilci, Cintia Carella, Jonas A Nilsson, Jennifer A Brennan, Sema Sirma, Ugur Ozbek, Kelli Boyd, John L Cleveland, Gerard C Grosveld

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Abstract

The human ETS family gene TEL2/ETV7 is highly homologous to TEL1/ETV6, a frequent target of chromosome translocations in human leukemia and specific solid tumors. Here we report that TEL2 augments the proliferation and survival of normal mouse B cells and dramatically accelerates lymphoma development in Emu-Myc transgenic mice. Nonetheless, inactivation of the p53 pathway was a hallmark of all TEL2/Emu-Myc lymphomas, indicating that TEL2 expression alone is insufficient to bypass this apoptotic checkpoint. Although TEL2 is infrequently up-regulated in human sporadic Burkitt's lymphoma, analysis of pediatric B-cell acute lymphocytic leukemia (B-ALL) samples showed increased coexpression of TEL2 and MYC and/or MYCN in over one-third of B-ALL patients. Therefore, TEL2 and MYC also appear to cooperate in provoking a cadre of human B-cell malignancies.

Original languageEnglish
Pages (from-to)2395-405
Number of pages11
JournalMolecular and Cellular Biology
Volume25
Issue number6
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Dive into the research topics of 'The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis'. Together they form a unique fingerprint.

Cite this